Beam Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Beam Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BEAM
Beam Therapeutics, Inc. is a biotechnology company, which engages in the establishment of integrated platform for precision genetic medicines. Its pipeline includes BEAM-101, BEAM-302, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-301, and BEAM-201.
CEOJohn Evans
CEOJohn Evans
Employees483
Employees483
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2017
Founded2017
Employees483
Employees483
BEAM Key Statistics
Market cap2.08B
Market cap2.08B
Price-Earnings ratio-4.43
Price-Earnings ratio-4.43
Dividend yield—
Dividend yield—
Average volume2.60M
Average volume2.60M
High today$21.72
High today$21.72
Low today$20.41
Low today$20.41
Open price$20.95
Open price$20.95
Volume2.18M
Volume2.18M
52 Week high$35.25
52 Week high$35.25
52 Week low$13.53
52 Week low$13.53
Analyst ratings
83%
of 18 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own BEAM. This list is generated using Robinhood data, and it’s not a recommendation.